These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 29751835)
1. Genome-wide association study identified ATP6V1H locus influencing cerebrospinal fluid BACE activity. Hu H; Li H; Li J; Yu J; Tan L; BMC Med Genet; 2018 May; 19(1):75. PubMed ID: 29751835 [TBL] [Abstract][Full Text] [Related]
2. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease. Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538 [TBL] [Abstract][Full Text] [Related]
3. Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer's subjects. Wu G; Sankaranarayanan S; Tugusheva K; Kahana J; Seabrook G; Shi XP; King E; Devanarayan V; Cook JJ; Simon AJ Clin Biochem; 2008 Aug; 41(12):986-96. PubMed ID: 18489907 [TBL] [Abstract][Full Text] [Related]
4. Polymorphism in the BACE gene influences the risk for Alzheimer's disease. Kirschling CM; Kölsch H; Frahnert C; Rao ML; Maier W; Heun R Neuroreport; 2003 Jul; 14(9):1243-6. PubMed ID: 12824768 [TBL] [Abstract][Full Text] [Related]
5. The association of beta-site APP cleaving enzyme (BACE) C786G polymorphism with Alzheimer's disease. Liu HC; Leu SJ; Chang JG; Sung SM; Hsu WC; Lee LS; Hu CJ Brain Res; 2003 Jan; 961(1):88-91. PubMed ID: 12535780 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease. Liu CG; Wang JL; Li L; Wang PC Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide association study identifies two loci influencing plasma neurofilament light levels. Li JQ; Yuan XZ; Li HY; Cao XP; Yu JT; Tan L; Chen WA; BMC Med Genomics; 2018 May; 11(1):47. PubMed ID: 29747637 [TBL] [Abstract][Full Text] [Related]
8. Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach. Martiskainen H; Helisalmi S; Viswanathan J; Kurki M; Hall A; Herukka SK; Sarajärvi T; Natunen T; Kurkinen KM; Huovinen J; Mäkinen P; Laitinen M; Koivisto AM; Mattila KM; Lehtimäki T; Remes AM; Leinonen V; Haapasalo A; Soininen H; Hiltunen M J Alzheimers Dis; 2015; 43(2):565-73. PubMed ID: 25096612 [TBL] [Abstract][Full Text] [Related]
9. Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease. Nicolaou M; Song YQ; Sato CA; Orlacchio A; Kawarai T; Medeiros H; Liang Y; Sorbi S; Richard E; Rogaev EI; Moliaka Y; Bruni AC; Jorge R; Percy M; Duara R; Farrer LA; St Georg-Hyslop P; Rogaeva EA Neurogenetics; 2001 Oct; 3(4):203-6. PubMed ID: 11714100 [TBL] [Abstract][Full Text] [Related]
10. BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology. Mulder SD; van der Flier WM; Verheijen JH; Mulder C; Scheltens P; Blankenstein MA; Hack CE; Veerhuis R J Alzheimers Dis; 2010; 20(1):253-60. PubMed ID: 20164582 [TBL] [Abstract][Full Text] [Related]
12. β-Site amyloid precursor protein-cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin-related receptor with A-type repeats, soluble amyloid precursor protein, and tau. Tsolakidou A; Alexopoulos P; Guo LH; Grimmer T; Westerteicher C; Kratzer M; Jiang M; Bujo H; Roselli F; Leante MR; Livrea P; Kurz A; Perneczky R Alzheimers Dement; 2013 Jul; 9(4):386-91. PubMed ID: 23127467 [TBL] [Abstract][Full Text] [Related]
13. Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1. Clarimón J; Bertranpetit J; Calafell F; Boada M; Tàrraga L; Comas D J Neurol; 2003 Aug; 250(8):956-61. PubMed ID: 12928915 [TBL] [Abstract][Full Text] [Related]
14. BACE: Therapeutic target and potential biomarker for Alzheimer's disease. Evin G; Barakat A; Masters CL Int J Biochem Cell Biol; 2010 Dec; 42(12):1923-6. PubMed ID: 20817005 [TBL] [Abstract][Full Text] [Related]
15. Genome-wide association study identifies Li X; Chu SG; Shen XN; Hou XH; Xu W; Ou YN; Dong Q; Tan L; Yu JT Aging (Albany NY); 2019 Nov; 11(21):9862-9874. PubMed ID: 31711042 [TBL] [Abstract][Full Text] [Related]
16. A Genome-Wide Association Study of α-Synuclein Levels in Cerebrospinal Fluid. Zhong XL; Li JQ; Sun L; Li YQ; Wang HF; Cao XP; Tan CC; Wang L; Tan L; Yu JT; Neurotox Res; 2019 Jan; 35(1):41-48. PubMed ID: 29959729 [TBL] [Abstract][Full Text] [Related]
17. Increased CSF-BACE1 activity associated with decreased hippocampus volume in Alzheimer's disease. Ewers M; Cheng X; Zhong Z; Nural HF; Walsh C; Meindl T; Teipel SJ; Buerger K; He P; Shen Y; Hampel H J Alzheimers Dis; 2011; 25(2):373-81. PubMed ID: 21460439 [TBL] [Abstract][Full Text] [Related]
19. Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice. Zohar O; Pick CG; Cavallaro S; Chapman J; Katzav A; Milman A; Alkon DL Neurobiol Aging; 2005; 26(8):1167-75. PubMed ID: 15917100 [TBL] [Abstract][Full Text] [Related]
20. Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein. Santosa C; Rasche S; Barakat A; Bellingham SA; Ho M; Tan J; Hill AF; Masters CL; McLean C; Evin G Neurobiol Dis; 2011 Jul; 43(1):176-83. PubMed ID: 21440067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]